Skip to content

A study to assess acute toxicities in lung carcinoma patients treated with curative intent of radiotherapy with modern radiotherapy technique

Assessment of acute toxicities in lung carcinoma patients treated with Radical intent of radiotherapy with VMAT technique- A Prospective Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/066252
Enrollment
40
Registered
2024-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C34- Malignant neoplasm of bronchus andlung

Interventions

Control Intervention1: nil: nil

Sponsors

Dr. Flavia Lyn Jashan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with histologically confirmed lung carcinoma. 2.Patients scheduled for radiotherapy with a radical intent using the VMAT technique. 3.Age 18 years or older. 4.Adequate baseline pulmonary function tests for safe participation

Exclusion criteria

Exclusion criteria: Lung cancer patients treated with palliative radiotherapy.

Design outcomes

Primary

MeasureTime frame
To assess the proportion of patients developing acute radiation pneumonitis as defined by CTCAE v5.0Timepoint: weekly during radiotherapy treatment and at treatment completion

Secondary

MeasureTime frame
To assess the level of change in quality of life using the EORTC QLQ-LC13 questionnaire.Timepoint: baseline,6 weeks,3months;To assess the proportion of patients achieving complete response after 6 months with repeat CECT/PET-CTTimepoint: 6 months;To assess the proportion of patients developing acute radiation esophagitis as defined by CTCAE v5.0Timepoint: 1 week,2 week,3 week,4 week,5 week,6 week;To report the dose constraints achieved with VMAT techniqueTimepoint: 6 weeks

Countries

India

Contacts

Public ContactDr Ambedkar Yadala

JIPMER

ambioncologist@gmail.com8940866067

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026